110 related articles for article (PubMed ID: 6162543)
41. In vitro biological evaluation of the R and S isomers of 1-(Tetrahydrofuran-2-yl)-5-fluorouracil.
Horwitz JP; McCormick JJ; Philips KD; Maher VM; Otto JR; Kessel D; Zemlicka J
Cancer Res; 1975 May; 35(5):1301-4. PubMed ID: 1168096
[TBL] [Abstract][Full Text] [Related]
42. 5-Fluorouracil (FUra).
Valeriote F; Santelli G
Pharmacol Ther; 1984; 24(1):107-32. PubMed ID: 6203132
[No Abstract] [Full Text] [Related]
43. Cytotoxicity of 5-nitro-2'-deoxyuridine by in vivo inhibition of thymidylate synthetase.
Washtien W; Matsuda A; Wataya Y; Santi DV
Biochem Pharmacol; 1978; 27(22):2663-6. PubMed ID: 215163
[No Abstract] [Full Text] [Related]
44. 5-Ethyl-2'-deoxyuridine-5'-monophosphate inhibition of the thymidylate synthetase from Escherichia coli.
Walter RD; Gauri KK
Biochem Pharmacol; 1975 May; 24(9):1025-7. PubMed ID: 1098667
[No Abstract] [Full Text] [Related]
45. Assay of 5-fluorodeoxyuridine 5'-monophosphate deoxyuridine 5'-monophosphate pools following 5-fluorouracil.
Myers CE; Young RC; Johns DG; Chabner BA
Cancer Res; 1974 Oct; 34(10):2682-8. PubMed ID: 4278001
[No Abstract] [Full Text] [Related]
46. A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity.
Ligasová A; Strunin D; Friedecký D; Adam T; Koberna K
PLoS One; 2015; 10(2):e0117459. PubMed ID: 25671308
[TBL] [Abstract][Full Text] [Related]
47. Nuclear morphology of yeast under thymidylate starvation.
Moens PB; Barclay BJ; Little JG
Chromosoma; 1981; 82(3):333-40. PubMed ID: 7014140
[TBL] [Abstract][Full Text] [Related]
48. Thymidylate synthetase inhibitors. Synthesis of N-substituted 5-aminomethyl-2'-deoxyuridine 5'-phosphates.
Edelman MS; Barfknecht RL; Huet-Rose R; Boguslawski S; Mertes MP
J Med Chem; 1977 May; 20(5):669-73. PubMed ID: 323484
[TBL] [Abstract][Full Text] [Related]
49. Failure of 5-fluorouracil and methotrexate to destroy the reproductive integrity of a human breast cancer cell line (MCF-7) growing in vitro.
Van den Berg HW; Clarke R; Murphy RF
Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1275-81. PubMed ID: 7200028
[No Abstract] [Full Text] [Related]
50. Interaction of 1-(5-phospho-beta-D-arabinofuranosyl)-5-substituted-uracils with thymidylate synthetase: mechanism-based inhibition by 1-(5-phospho-beta-D-arabinosyl)-5-fluorouracil.
Nakayama C; Wataya Y; Santi DV; Saneyoshi M; Ueda T
J Med Chem; 1981 Oct; 24(10):1161-5. PubMed ID: 7328576
[TBL] [Abstract][Full Text] [Related]
51. Effect of 5-fluorouracil on the cell growth and cell cycle kinetics of a mouse ascites tumor growing in vivo.
Lewin F; Skog S; Tribukait B; Ringborg U
Acta Oncol; 1987; 26(2):125-31. PubMed ID: 3606867
[TBL] [Abstract][Full Text] [Related]
52. Proceedings: Inhibitors of thymidylate synthetase as R factor curing agents.
Bremer K; Pinney RJ; Smith JT
J Pharm Pharmacol; 1973 Dec; 25():Suppl:131P-132. PubMed ID: 4150531
[No Abstract] [Full Text] [Related]
53. Letter: 5-iodoacetamidomethyl-2'-deoxyuridine 5'-phosphate. A selective inhibitor of mammalian thymidylate synthetases.
Barfknecht RL; Huet-Rose RA; Kampf A; Mertes MP
J Am Chem Soc; 1976 Aug; 98(16):5041-3. PubMed ID: 950429
[No Abstract] [Full Text] [Related]
54. [Radiotherapy following synchronisation of the cell-division rhythm].
Nitze HR; Ganzer U; Vosteen KH
Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:11-2. PubMed ID: 4344512
[No Abstract] [Full Text] [Related]
55. In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.
Camplejohn RS; Schultze B; Maurer W
Br J Cancer; 1977 May; 35(5):546-56. PubMed ID: 861145
[TBL] [Abstract][Full Text] [Related]
56. [Heterogeneity of mouse sarcoma cells based on tumorigenicity determined by the different degree of contact inhibition of cell division].
Lavrovskiĭ VA; Ustinov AS
Biull Eksp Biol Med; 1988 Jul; 106(7):88-91. PubMed ID: 3401586
[TBL] [Abstract][Full Text] [Related]
57. The enhancement of 5-fluorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherol.
Waxman S; Bruckner H
Eur J Cancer Clin Oncol; 1982 Jul; 18(7):685-92. PubMed ID: 6982167
[No Abstract] [Full Text] [Related]
58. Utilization of purine and pyrimidine in human gastric cancer cells (KATO III): effect of a nucleotide and nucleosides mixture (OG-VI) solution on proliferation with coadministration of 5-fluorouracil.
Usami M; Zheng JH; Wang J; Yasuda I; Haji S; Kotani G; Iso A; Sun K; Sakata K; Ohta K
Adv Exp Med Biol; 1994; 370():131-4. PubMed ID: 7660875
[No Abstract] [Full Text] [Related]
59. Fluorouracil: mechanism of action in human skin and actinic keratoses. I. Effect on DNA synthesis in vivo.
Eaglstein WH; Weinstein GD; Frost P
Arch Dermatol; 1970 Feb; 101(2):132-9. PubMed ID: 5413250
[No Abstract] [Full Text] [Related]
60. Prevention of antitumor effect of 5-fluorouracil by hypoxanthine.
Yoshida M; Hoshi A; Kuretani K
Biochem Pharmacol; 1978; 27(24):2979-82. PubMed ID: 736994
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
